Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (22)
Wieslaw M. Kazmierski, Sam Baskaran, Jill T. Walker, Nagaraju Miriyala, Ramu Meesala, Mallesh Beesu, George Adjabeng, Richard M. Grimes, Robert Hamatake, Martin R. Leivers, Renae Crosby, Bing Xia & Katja Remlinger. (2020) GSK2818713, a Novel Biphenylene Scaffold-Based Hepatitis C NS5A Replication Complex Inhibitor with Broad Genotype Coverage. Journal of Medicinal Chemistry 63:8, pages 4155-4170.
Crossref
Crossref
Jeffrey J. Pouliot, Michael Thomson, Mi Xie, Joseph Horton, John Johnson, David Krull, Amanda Mathis, Yoshio Morikawa, Derek Parks, Richard Peterson, Takashi Shimada, Elizabeth Thomas, Jessica Vamathevan, Stephanie Van Horn, Zhiping Xiong, Robert Hamatake & Andrew J. Peat. (2015)
Preclinical Characterization and
In Vivo
Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein
. Antimicrobial Agents and Chemotherapy 59:10, pages 6539-6550.
Crossref
Crossref
Maxwell D. Cummings, Tse-I Lin, Lili Hu, Abdellah Tahri, David McGowan, Katie Amssoms, Stefaan Last, Benoit Devogelaere, Marie-Claude Rouan, Leen Vijgen, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Erna Cleiren, Liesbet van der Helm, Gregory Fanning, Origène Nyanguile, Kenny Simmen, Pieter Van Remoortere, Pierre Raboisson & Sandrine Vendeville. (2013) Discovery and Early Development of TMC647055, a Non-Nucleoside Inhibitor of the Hepatitis C Virus NS5B Polymerase. Journal of Medicinal Chemistry 57:5, pages 1880-1892.
Crossref
Crossref
Jill Walker, Renae Crosby, Amy Wang, Ermias Woldu, Jessica Vamathevan, Christian Voitenleitner, Shihyun You, Katja Remlinger, Maoshang Duan, Wieslaw Kazmierski & Robert Hamatake. (2014) Preclinical Characterization of GSK2336805, a Novel Inhibitor of Hepatitis C Virus Replication That Selects for Resistance in NS5A. Antimicrobial Agents and Chemotherapy 58:1, pages 38-47.
Crossref
Crossref
Christian Voitenleitner, Renae Crosby, Jill Walker, Katja Remlinger, Jessica Vamathevan, Amy Wang, Shihyun You, John JohnsonIIIIII, Ermias Woldu, Stephanie Van Horn, Joseph Horton, Katrina Creech, J. Brad Shotwell, Zhi Hong & Robert Hamatake. (2013)
In Vitro
Characterization of GSK2485852, a Novel Hepatitis C Virus Polymerase Inhibitor
. Antimicrobial Agents and Chemotherapy 57:11, pages 5216-5224.
Crossref
Crossref
Pierre L. Beaulieu. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs
248
294
.
Pierre L. BeaulieuRené CoulombeJames GillardChristian BrochuJianmin DuanMichel GarneauEric JolicoeurPeter KuhnMarc-André PoupartJean RancourtTimothy A. StammersBounkham ThavonekhamGeorge Kukolj. (2013)
Allosteric
N-
acetamide-indole-6-carboxylic acid thumb pocket 1 inhibitors of hepatitis C virus NS5B polymerase — Acylsulfonamides and acylsulfamides as carboxylic acid replacements
. Canadian Journal of Chemistry 91:1, pages 66-81.
Crossref
Crossref
David McGowan, Sandrine Vendeville, Tse-I Lin, Abdellah Tahri, Lili Hu, Maxwell D. Cummings, Katie Amssoms, Jan Martin Berke, Maxime Canard, Erna Cleiren, Pascale Dehertogh, Stefaan Last, Els Fransen, Elisabeth Van Der Helm, Iris Van den Steen, Leen Vijgen, Marie-Claude Rouan, Gregory Fanning, Origène Nyanguile, Kristof Van Emelen, Kenneth Simmen & Pierre Raboisson. (2012) Finger-loop inhibitors of the HCV NS5b polymerase. Part 1: Discovery and optimization of novel 1,6- and 2,6-macrocyclic indole series. Bioorganic & Medicinal Chemistry Letters 22:13, pages 4431-4436.
Crossref
Crossref
Maxwell D. Cummings, Tse‐I Lin, Lili Hu, Abdellah Tahri, David McGowan, Katie Amssoms, Stefaan Last, Benoit Devogelaere, Marie‐Claude Rouan, Leen Vijgen, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Erna Cleiren, Liesbet van der Helm, Gregory Fanning, Kristof Van Emelen, Origène Nyanguile, Kenny Simmen, Pierre Raboisson & Sandrine Vendeville. (2012) Structure‐Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties. Angewandte Chemie International Edition 51:19, pages 4637-4640.
Crossref
Crossref
Maxwell D. Cummings, Tse‐I Lin, Lili Hu, Abdellah Tahri, David McGowan, Katie Amssoms, Stefaan Last, Benoit Devogelaere, Marie‐Claude Rouan, Leen Vijgen, Jan Martin Berke, Pascale Dehertogh, Els Fransen, Erna Cleiren, Liesbet van der Helm, Gregory Fanning, Kristof Van Emelen, Origène Nyanguile, Kenny Simmen, Pierre Raboisson & Sandrine Vendeville. (2012) Structure‐Based Macrocyclization Yields Hepatitis C Virus NS5B Inhibitors with Improved Binding Affinities and Pharmacokinetic Properties. Angewandte Chemie 124:19, pages 4715-4718.
Crossref
Crossref
Frank Narjes, Benedetta Crescenzi, Marco Ferrara, Jörg Habermann, Stefania Colarusso, Maria del Rosario Rico Ferreira, Ian Stansfield, Angela Claire Mackay, Immacolata Conte, Caterina Ercolani, Simone Zaramella, Maria-Cecilia Palumbi, Philip Meuleman, Geert Leroux-Roels, Claudio Giuliano, Fabrizio Fiore, Stefania Di Marco, Paola Baiocco, Uwe Koch, Giovanni Migliaccio, Sergio Altamura, Ralph Laufer, Raffaele De Francesco & Michael Rowley. (2010)
Discovery of (7
R
)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6
H
-indolo[1,2-
e
][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase
. Journal of Medicinal Chemistry 54:1, pages 289-301.
Crossref
Crossref
Ryan C. Durk, Kamalendra Singh, Ceili A. Cornelison, Devendra K. Rai, Kayla B. Matzek, Maxwell D. Leslie, Elizabeth Schafer, Bruno Marchand, Adeyemi Adedeji, Eleftherios Michailidis, Christopher A. Dorst, Jennifer Moran, Christie Pautler, Luis L. Rodriguez, Mark A. McIntosh, Elizabeth Rieder & Stefan G. Sarafianos. (2010) Inhibitors of Foot and Mouth Disease Virus Targeting a Novel Pocket of the RNA-Dependent RNA Polymerase. PLoS ONE 5:12, pages e15049.
Crossref
Crossref
Shayne Cox GadAlexander V. Lyubimov & Ihor Bekersky. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Pierre L. Beaulieu, Eric Jolicoeur, James Gillard, Christian Brochu, René Coulombe, Nathalie Dansereau, Jianmin Duan, Michel Garneau, Araz Jakalian, Peter Kühn, Lisette Lagacé, Steven LaPlante, Ginette McKercher, Stéphane Perrault, Martin Poirier, Marc-André Poupart, Timothy Stammers, Louise Thauvette, Bounkham Thavonekham & George Kukolj. (2010) N-Acetamideindolecarboxylic acid allosteric ‘finger-loop’ inhibitors of the hepatitis C virus NS5B polymerase: discovery and initial optimization studies. Bioorganic & Medicinal Chemistry Letters 20:3, pages 857-861.
Crossref
Crossref
Hui LiStephanie T Shi. (2010) Non-nucleoside inhibitors of hepatitis C virus polymerase: current progress and future challenges. Future Medicinal Chemistry 2:1, pages 121-141.
Crossref
Crossref
Jose Ignacio Martin Hernando, Jesus Maria Ontoria, Savina Malancona, Barbara Attenni, Fabrizio Fiore, Fabio Bonelli, Uwe Koch, Stefania Di Marco, Stefania Colarusso, Simona Ponzi, Nadia Gennari, Sue Ellen Vignetti, Maria del Rosario Rico Ferreira, Jörg Habermann, Michael Rowley & Frank Narjes. (2009) Optimization of Thienopyrrole-Based Finger-Loop Inhibitors of the Hepatitis C Virus NS5B Polymerase. ChemMedChem 4:10, pages 1695-1713.
Crossref
Crossref
Xinning Yang, Yash A. Gandhi, David B. Duignan & Marilyn E. Morris. (2009) Prediction of Biliary Excretion in Rats and Humans Using Molecular Weight and Quantitative Structure–Pharmacokinetic Relationships. The AAPS Journal 11:3.
Crossref
Crossref
Ralph Laufer, Odalys Gonzalez Paz, Annalise Di Marco, Fabio Bonelli, Edith Monteagudo, Vincenzo Summa & Michael Rowley. (2009) Quantitative Prediction of Human Clearance Guiding the Development of Raltegravir (MK-0518, Isentress) and Related HIV Integrase Inhibitors. Drug Metabolism and Disposition 37:4, pages 873-883.
Crossref
Crossref
Monica Donghi, Barbara Attenni, Cristina Gardelli, Annalise Di Marco, Fabrizio Fiore, Claudio Giuliano, Ralph Laufer, Joseph F. Leone, Vincenzo Pucci, Michael Rowley & Frank Narjes. (2009) Synthesis and evaluation of novel phosphoramidate prodrugs of 2′-methyl cytidine as inhibitors of hepatitis c virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters 19:5, pages 1392-1395.
Crossref
Crossref
Origène Nyanguile, Frederik Pauwels, Walter Van den Broeck, Carlo W. Boutton, Ludo Quirynen, Tania Ivens, Liesbet van der Helm, Geneviève Vandercruyssen, Wendy Mostmans, Frédéric Delouvroy, Pascale Dehertogh, Maxwell D. Cummings, Jean-Francois Bonfanti, Kenneth A. Simmen & Pierre Raboisson. (2008) 1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors. Antimicrobial Agents and Chemotherapy 52:12, pages 4420-4431.
Crossref
Crossref
Raffaele De Francesco & Andrea Carfí. (2007) Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Advanced Drug Delivery Reviews 59:12, pages 1242-1262.
Crossref
Crossref
Andrew V. StachulskiJohn R. HardingJohn C. LindonJames L. MaggsB. Kevin ParkIan D. Wilson. (2006) Acyl Glucuronides: Biological Activity, Chemical Reactivity, and Chemical Synthesis. Journal of Medicinal Chemistry 49:24, pages 6931-6945.
Crossref
Crossref